-
Mashup Score: 1
Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug on Wednesday, reassuring investors worried that demand was slowing and it could lose the race in the fast-growing obesity drug market.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Drugmaker Granules India reported a 4.8% fall in its second-quarter profit on Wednesday, dragged by a slow demand in the North American and European markets.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Novo Nordisk CEO on Wegovy prices, supplies and compounding - 3 hour(s) ago
Novo Nordisk reported forecast-beating quarterly sales of its popular Wegovy weight-loss drug on Wednesday, sending its shares up nearly 9%.
Source: www.reuters.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Teva Pharmaceutical third-quarter profit, revenue top estimates - 3 hour(s) ago
Teva Pharmaceutical Industries reported a larger than expected rise in third-quarter profit, boosted by strong sales of copycat medicines and its branded drugs to treat migraines and Huntington’s disease.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
CVS Health on Wednesday named Steve Nelson, a former UnitedHealth insurance head, to run its Aetna business, where rising medical costs in the third quarter caused the company to preannounce an earnings miss last month.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Novo Nordisk says its experimental drug CagriSema has similar side effects to Wegovy - 5 hour(s) ago
Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 drugs already on the market, and reiterated its expectation the new injection will deliver 25% weight loss.
Source: www.reuters.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1
Novo Nordisk is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States and is increasing supply in that market, its CEO said on Wednesday.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
Germany’s Fresenius raised its full-year outlook on Wednesday after beating third-quarter expectations, citing strong performances at its Kabi and Helios divisions and deleveraging efforts paying off, sending shares up.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Drugmaker Granules India reported a 4.8% fall in its second-quarter profit on Wednesday, dragged by a slow demand in the North American and European markets.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1UK government confirms spread of bird flu in commercial poultry - 8 hour(s) ago
The UK government said on Tuesday it has confirmed a strain of the H5N5 bird flu virus in commercial poultry at a premises near Hornsea in Yorkshire.
Source: www.reuters.comCategories: General Medicine News, General HCPsTweet
Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug on Wednesday, reassuring investors worried that demand was slowing and it could lose the race in the fast-growing obesity drug market. https://t.co/lq62TU0Yi0 https://t.co/lq62TU0Yi0